|
New York, NY, November 9, 2009-Ebitda News reports that EBITDA for Endo Pharmaceuticals Holdings, Inc. (NASDAQ:ENDP) for its quarter ended September 30, 2009 was $90,926,000, a 24% decrease over the y ... read full story |
|
| Website Address: |
www.endo.com |
| Industry: |
Misc Pharmaceuticals
|
|